Insights

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Roswell and CC collaborated to develop the world’s first molecular electronics chip for healthcare diagnostics. Roswell has ‘digitised biology’ enabling a sample to be placed on a chip that can run multiple tests, transforming the diagnostics industry from one-test-one-result to one-test-many-results.

Cambridge Consultants expands its innovation partnership with MedTech Innovator to help accelerate  medtech start ups 

What is semi-supervised machine learning? And what could it mean for the research and development of a new generation of AI-powered digital medical systems? Andrew Goulter reports on state-of-the art deep learning research at CC that promises huge savings in the time and expense of development, while augmenting the skills of pathologists… 

It soon becomes crunch time for an entrepreneurial start up with a ground-breaking idea in tough tech innovation. While exploring some of the details of CC’s workshop approach, Roger Mainwaring-Burton reveal the secrets of taking a product, service or company from benchtop to scale to success in the market…

Potential quantum attacks on government agencies and the military are part and parcel of the changing security landscape. In turn, government organizations are exploring the use of quantum for defense security, as well as the efficiencies of future states that these technologies will enable for mission-critical operations.

A meeting of minds - AI meets biology. This is the conversation that is bridging the gap between bioprocessing and machine learning.

What is quantum computing? That’s a question still being asked by much of the world’s C-suite. But here at CC our multidisciplinary teams of physicists, engineers and designers are already helping to plot a credible pathway for a future powered by quantum technologies…

What can quantum computing and quantum technology do for the pharma and life sciences industry? After reviewing the latest signs of quantum innovation in practice across Europe, Elizabeth Thomas has conferred with Cambridge Consultants’ quantum experts and now shares her insights into how organisations can start implementing an action plan… 

Fresh from the Festival of Genomics and Biodata, our Head of Life Sciences Symon Cotton reflected on the future of the genomics ecosystem. Here he discusses how genomics – plus the emergence of panomics and long read sequencing – could inform clinical practice and patient care…